Held in Chicago, ACC 2025 is the premier event for exploring breakthroughs in cardiovascular research. Attendees will benefit from high-impact sessions, hands-on workshops, and networking opportunities. Our team will share key insights and discuss initiatives aimed at addressing challenges in heart health. Whether you’re looking to expand your research capabilities or collaborate on innovative treatments, we’re eager to connect with you.

Latest news

Von Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

First patient enrolled in telehealth study, the Pathway Study

February 25, 2025
The Pathway study is based on pioneering work during the pandemic between clinicians at Richmond Pharmacology and the National Amyloidosis Centre and aims...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event